Brain illustration with abstract flavor cues showing how e-cigarette flavor patterns influence smoking cessation behavior

How Flavor Choice and Vaping Patterns Shape Smoking Cessation Outcomes

A new open-access study in Nicotine & Tobacco Research offers rare clarity on how e-cigarette use patterns influence smoking cessation. Analyzing data from 886 participants in a large randomized controlled trial, researchers found that non-tobacco flavors were preferred and linked with higher quit success, nicotine strength declined over time, and dual users - those smoking and vaping simultaneously - were more likely to quit later. The results provide practical, evidence-based guidance for clinicians advising smokers who want to quit using e-cigarettes.

By Seven Reflections Editorial - December 10, 2025 in Neuroscience & Health


Most research on e-cigarettes has focused on whether they help smokers quit, but far less is known about how smokers should use them to maximize their chances of success. A new secondary analysis of a large randomized controlled trial now sheds light on flavor preferences, nicotine-strength transitions, behavioral trajectories, and the role of early dual use. These details matter, because they influence not only immediate withdrawal relief but also long-term smoking outcomes.

The study draws on data from the Trial of Electronic Cigarettes (TEC), which compared combination nicotine replacement therapy (NRT) to starter-kit e-cigarettes among 886 adults seeking to quit. While the original trial established that e-cigarettes yielded higher quit rates than NRT, the new analysis digs deeper into the behavioral patterns behind those outcomes. Participants in the e-cigarette arm received a refillable device and tobacco-flavored 18 mg/mL e-liquid, but were free to choose flavors, strengths, and devices afterward, creating a naturalistic window into real-world use.

One of the clearest findings involves flavor choice. Tobacco flavor, though commonly supplied in cessation programs, was unpopular. Half of users abandoned it in the first four weeks, and only about one quarter were still using it at one year. In contrast, fruit and sweet flavors became increasingly dominant over time. This shift was not merely a matter of taste: those still using tobacco-flavored e-liquids at one year had substantially lower quit rates than those who switched to other flavors. The relative risk of quitting for tobacco-flavor users was reduced by nearly half. This suggests that non-tobacco flavors may reduce sensory associations with smoking, making abstinence easier to maintain.

Nicotine strength also changed over time. Although most participants began with the 18 mg/mL e-liquid provided in their starter kit, many reduced nicotine concentration as the months passed. By one year, a meaningful subset - about 10% - had transitioned entirely to nicotine-free e-liquid. Those who remained abstinent were using lower nicotine strengths than those who continued smoking, consistent with the idea that stable abstinence naturally allows for a downward taper rather than forced reduction. Yet at the four-week mark, nicotine strength did not predict later success, likely because most users were still exploring product options.

The study also examines whether switching device types affects cessation. While the majority continued using refillable systems, a substantial proportion moved away from the starter device to another model of their own choosing. These changes did not predict quitting or smoking reduction, suggesting that allowing smokers to personalize their vaping device does not undermine cessation - and may even support it by improving satisfaction and adherence.

One of the most notable results concerns dual use, often viewed with concern by clinicians and policy makers. Dual users at early time points were more likely to quit smoking later than exclusive smokers. At week one, dual users were over four times as likely to be abstinent at week four compared to smokers who were not vaping. A similar pattern appeared at four weeks and six months: dual users were significantly more likely to achieve validated reductions in smoke intake and more likely to stop smoking altogether by one year. Rather than hindering cessation, early dual use appears to function as a transitional phase, in which switching between nicotine sources weakens the reinforcing pull of cigarettes.

This pattern may be partly explained by the study's findings on craving and withdrawal. Across multiple time points, e-cigarette users experienced lower urges to smoke than NRT users, both among those quitting and those still smoking. Because withdrawal discomfort strongly predicts relapse, an intervention that rapidly and reliably reduces urges can meaningfully shift outcomes. For abstainers, e-cigarettes produced lower craving scores at weeks one and four, suggesting that vaping provides more immediate or more satisfying relief compared to standard NRT formulations.

Importantly, these results speak directly to clinical decision-making. Smokers attempting to quit with e-cigarettes can be advised that non-tobacco flavors not only are widely preferred but may improve long-term outcomes. Clinicians can reassure patients that dual use is not a sign of failure; rather, people who combine smoking and vaping early in a quit attempt often reduce cigarette use dramatically and quit later with higher success rates. Additionally, a gradual self-directed reduction in nicotine strength is common and does not need to be forced early in the cessation process.

From the lens of Seven Reflections' Dimensional Systems Architecture (DSA), these behavioral trajectories reflect shifts in cognitive-field patterns rather than simple product choices. Flavor transitions reduce associative memory loops by decoupling sensory cues from the smoking habit, effectively weakening a high-salience reward pathway. Nicotine-strength reduction represents an adaptive recalibration of internal regulatory fields as dependence declines. And dual use mirrors a transitional-state dynamic: the system oscillates between two nicotine sources, increasing variability and decreasing the stability of the old behavioral attractor - combustible smoking - until the system reorganizes into a new equilibrium. In DSA terms, quitting is not a single event but a progressive field reconfiguration driven by reduced withdrawal pressure, altered sensory input, and increased behavioral optionality.

The study's observational nature limits causal claims, and self-selection into e-cigarette use may reflect motivational or psychological traits not fully captured in the data. Nonetheless, the findings provide one of the clearest, empirically grounded guides for clinicians and smokers seeking practical advice. E-cigarettes appear most effective when users personalize flavor, taper nicotine at their own pace, and do not interpret dual use as failure. Instead of rigid rules, cessation emerges from gradual shifts in reinforcement, craving, and sensory - behavioral alignment.


References

Francesca Pesola, PhD , Katie Myers Smith, DPsych , Dunja Przulj, PhD , Daniella Ladmore, MSc , Anna Phillips-Waller, BSc , Hayden McRobbie, PhD , Peter Hajek, PhD (2025). Patterns of e-Cigarette Use and Smoking Cessation Outcomes: Secondary Analysis of a Large Randomised Controlled Trial to Inform Clinical Advice. [Nicotine & Tobacco Research] https://doi.org/10.1093/ntr/ntaf240...

Leave a Comment


Smoking cannabis with tobacco may disrupt the brains natural calming system, study suggests

Smoking cannabis with tobacco may disrupt the brain's natural calming system, study suggests

A preliminary imaging study in Drug and Alcohol Dependence Reports suggests that people who smoke cannabis together with tobacco may experience measurable disruptions to the brain's endocannabinoid system - a network involved in stress regulation, mood, and emotional balance. Using positron emission tomography, researchers found elevated levels of FAAH, an enzyme that breaks down the calming endocannabinoid anandamide, in those who co-used tobacco compared with cannabis-only users. The discovery highlights a potential neurobiological reason why co-use is often linked to worse clinical outcomes.

Study Finds THC Can Remain in Blood for Days Without Affecting Driving
Nov 12, 2025 Cognitive Science

Study Finds THC Can Remain in Blood for Days Without Affecting Driving

A new study published in Clinical Chemistry challenges the scientific basis of current per se and zero-tolerance laws for cannabis-related driving impairment. Researchers found that many regular cannabis users still exceeded legal THC blood thresholds several days after their last use, despite showing no signs of diminished driving performance. The findings raise questions about how impairment is defined and whether existing laws accurately reflect biological and behavioral realities surrounding cannabis use.

Eye Drop Misuse Raises Cognitive Risks in Heroin Users

Eye Drop Misuse Raises Cognitive Risks in Heroin Users

A new study from the Okasha Institute of Psychiatry (Ain Shams University, Egypt) reveals a troubling trend: some intravenous heroin users have begun misusing anticholinergic eye drops to intensify their high - at the cost of their cognitive health. The research compared heroin users, dual users, and healthy controls, uncovering significantly greater impairments in attention and processing speed among those combining heroin with anticholinergic drops. While all heroin users showed cognitive disruption, this emerging form of polysubstance use appears to impose an additional and specific cognitive burden.

How Long-Term EEG Recordings Reveal the Hidden Predictability of Human Sleep
Nov 29, 2025 Sleep & Dreaming

How Long-Term EEG Recordings Reveal the Hidden Predictability of Human Sleep

A new open-access study in Brain Communications charts human sleep with unprecedented precision, using ultra-long subscalp EEG recordings collected continuously over weeks. Despite night-to-night variability, the researchers discovered stable oscillatory patterns shared across individuals that allow NREM - REM transitions to be predicted minutes in advance. By analyzing frequency-band dynamics across more than 30 nights per person, the study offers a deeper view of sleep architecture and its potential use in future clinical interventions.

What a Review of 100 Million Adults Suggests About Vaccination and Dementia Risk
Nov 21, 2025 Neuroscience & Health

What a Review of 100 Million Adults Suggests About Vaccination and Dementia Risk

A new open-access systematic review published in Age and Ageing analyzes more than 100 million adults to examine whether routine vaccinations are associated with subsequent dementia risk. The study reviewed observational data across multiple countries and vaccine types, reporting several correlations between vaccination history and lower dementia incidence. While these associations do not establish causation, they highlight possible links between infection prevention, inflammation, and long-term brain health. The findings contribute to ongoing research exploring modifiable factors that may influence cognitive ageing.

How Different Stress-Resilience Techniques Shape Depression and Stress Recovery
Nov 28, 2025 Cognitive Science

How Different Stress-Resilience Techniques Shape Depression and Stress Recovery

A new randomized controlled pilot trial published in Annals of Behavioral Medicine reports that both calming and stimulating stress-resilience practices can reduce depressive symptoms and perceived stress within weeks. The study tested mindfulness, slow breathing with warm showers, the Wim Hof Method, and high-intensity interval training among highly stressed women. While all approaches led to short-term improvements, participants who followed the Wim Hof Method showed modestly more sustained gains three months later. The findings refine how both low- and high-arousal strategies support human stress regulation.